RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Single-Stranded RNA Origami Remodels Macrophage to Promote the Synergistic Antitumor Effect with 5‑Fluorouracil in Pancreatic Cancer.
Single-Stranded RNA Origami Remodels Macrophage to Promote the Synergistic Antitumor Effect with 5‑Fluorouracil in Pancreatic Cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
癌症免疫治疗的进展集中在开发不仅能靶向肿瘤进展,还能增强免疫反应的疗法,这有可能改变肿瘤微环境(TME)内的平衡,促进更具免疫活性的环境,并提高抗肿瘤免疫疗法的有效性。
本研究评估了单链RNA折纸(ssRNAOG)在体外模拟TME的共培养模型中的内化,以及ssRNAOG与5-氟尿嘧啶(5-FU)联合在胰腺导管腺癌(PDAC)模型中的抗肿瘤疗效。ssRNAOG的内化触发TLR3信号通路,导致强烈的先天免疫激活。
值得注意的是,ssRNAOG诱导巨噬细胞上MHC I类蛋白的过表达,从而将NK细胞招募到TME中。ssRNAOG与5-FU的联合在体外显著抑制了肿瘤细胞集落形成,表现出协同抗增殖效应。转录组学和蛋白质组学分析显示,炎症细胞因子显著上调,NF-κB和STAT1激活,这表明巨噬细胞向M1样极化。在体内给予ssRNAOG和5-FU后,携带PDAC异种移植瘤的小鼠肿瘤负荷显著减少,生存期延长。免疫组织化学显示巨噬细胞极化向M1样表型转变,这与促炎反应增强和肿瘤增殖减少相关。这些发现表明,ssRNAOG作为一种有效的TME调节剂,能够使耐药肿瘤对化疗敏感,为PDAC提供了一种新的免疫治疗策略。
The advancement of cancer immunotherapy has focused on developing therapies that not only target tumor progression but also enhance immune responses, which could potentially shift the balance within the tumor microenvironment (TME) to promote a more immune-competent environment and improve the effectiveness of antitumor immunotherapies.
This study evaluates the internalization of single-stranded RNA origami (ssRNAOG) in coculture models mimicking the TME in vitro and the antitumor efficacy of the combination of ssRNAOG with 5-fluorouracil (5-FU) in pancreatic ductal adenocarcinoma (PDAC) models. The internalization of ssRNAOG triggers the TLR3 signaling pathway, leading to robust innate immune activation.
Notably, ssRNAOG induces the overexpression of MHC class I protein on macrophages, which recruits NK cells into the TME. The combination of ssRNAOG and 5-FU significantly suppressed tumor cell colony formation in vitro, demonstrating a synergistic antiproliferative effect. Transcriptomic and proteomic analyses revealed a significant upregulation of inflammatory cytokines and the activation of NF-κB and STAT1, which are indicative of M1-like polarization in macrophages.
In vivo administration of both ssRNAOG and 5-FU revealed a marked reduction in tumor burden and an extension of survival in mice bearing xenograft PDAC tumors. Immunohistochemistry revealed a shift in macrophage polarization toward the M1-like phenotype, which is associated with enhanced proinflammatory responses and reduced tumor proliferation.
These findings indicate that ssRNAOG, as a potent modulator of the TME that can sensitize resistant tumors to chemotherapy, presents a novel immunotherapeutic strategy for PDAC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。